Child Psychiatry - Articles - Page 54

Improving Quality of Care for Autism

January 1, 2013

David Mandell, ScD
Associate Professor, psychiatry and pediatrics Director, Center for Mental Health Policy and Services Research The University of Pennsylvania Perelman School of Medicine Dr. Mandell has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

Dr. Mandell discusses the strategies and approaches that have an evidence base for working with autism, the impact autism has on families and the importance of inclusion.

The DSM-5 Field Trials: What They Mean for Child Psychiatry

January 1, 2013

Editor-in-Chief, Caroline Fisher, PhD, MD

In advance of the official release of DSM-5 this May, the field trial data has been reported in three papers in the American Journal of Psychiatry.

Learning Objectives, Autism Spectrum Disorders, CCPR, January/February 2013

January 1, 2013

After reading these articles, you should be able to…

Pharmacologic Treatment of Youth with Bipolar Disorder: Where to Next?

December 1, 2012

Benjamin I. Goldstein, PhD, MD

Bipolar disorder presents unique pharmacologic challenges. Those treating children or adolescents with bipolar disorder face the additional challenge of having far less information to inform their treatment decisions.

Letter from the Editors

December 1, 2012

The diagnosis, treatment, and very existence of pediatric bipolar disorder is one of the most contentious debates in our field.

How We Got Here: The Psychodynamics of Juvenile Bipolar Disorder and the Clinician

December 1, 2012

Jennifer Harris, MD

The studies have been done and the consensus is in. Juvenile bipolar disorder (JBD) has probably been overdiagnosed recently, and the DSM-5 will describe a narrower phenotype to qualify for the diagnosis. At this point, it is worth thinking about how we got here, and what it means for clinicians as a cautionary tale for the future.

Pediatric Bipolar Disorder (PBD): A Skeptical, Mainstream, Non-US Perspective

December 1, 2012

Peter Parry, MBBS

Although practicing in Australia, I have followed the PBD phenomenon in the USA for several years. PBD had become the most common diagnosis in pre-pubertal children in US psychiatric inpatient units by 2004.

Amber Light Therapy for Bipolar Disorder

December 1, 2012

Ki Kurtz, DO

What bipolar patients, as well as their doctors, may not know is the amount of current research centered on light-dark therapy and the potential implications of this research on treating bipolar.

Severe Mood Dysregulation (SMD) and Pediatric Bipolar Disorder

December 1, 2012

Are children with severe mood dysregulation (SMD) at a greater risk for developing bipolar disorder? Dr. Leibenluft explains her extensive research on this subject.

Brain Function and Bipolar Disorder

December 1, 2012

What are the differences in the brains of children with bipolar disorder and how can we use this information in the treatment of pediatric bipolar disorder? Dr. Pavuluri takes us through her pediatric brain research findings.

Child Psychiatry
RSS

Improving Quality of Care for Autism

The DSM-5 Field Trials: What They Mean for Child Psychiatry

Learning Objectives, Autism Spectrum Disorders, CCPR, January/February 2013

Pharmacologic Treatment of Youth with Bipolar Disorder: Where to Next?

Letter from the Editors

How We Got Here: The Psychodynamics of Juvenile Bipolar Disorder and the Clinician

Pediatric Bipolar Disorder (PBD): A Skeptical, Mainstream, Non-US Perspective

Amber Light Therapy for Bipolar Disorder

Severe Mood Dysregulation (SMD) and Pediatric Bipolar Disorder

Brain Function and Bipolar Disorder

Psychiatry Practice Boosters, Fourth Edition (2023)

KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

Should You Test MTHFR?

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

About

Shop Online

Newsletters

Contact

Follow Us

Child Psychiatry RSS

About

Shop Online

Newsletters

Contact

Follow Us

Child Psychiatry
RSS